Cardinal Health, Inc.
Financials
Valuation Metrics
Cardinal Health, Inc.'s Market Cap is $55.20B. At end of 2025 it was $48.38B. Ranked #302 of 3,111 in US market (top 10%), #222 of 1,666 on NYSE (top 13%), #15 of 206 in Health Care Equipment & Services (top 7%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $55.20B | US#302/3,111 Sec#15/206 |
| Revenue | $250.55B | US#20/3,111 Sec#6/206 |
| Net Income | $1.56B | US#390/3,111 Sec#17/206 |
| Total Assets | $56.69B | US#300/3,111 Sec#14/206 |
| Net Assets | $998M | US#1,781/3,111 Sec#96/206 |
| Employees | 53,084 | US#162/3,111 Sec#21/206 |
| Value | ||
| P/E | 35.40x | US#1,601/3,111 Sec#64/206 |
| P/B | 55.31x | US#2,939/3,111 Sec#200/206 |
| P/S | 0.22x | US#91/3,111 Sec#9/206 |
| EV/EBITDA | 19.89x | US#1,827/3,111 Sec#80/206 |
| FCF Yield | 7.96% | US#729/3,111 Sec#29/206 |
| Profitability | ||
| ROE | 156.21% | US#9/3,111 Sec#1/206 |
| ROA | 2.75% | US#1,452/3,111 Sec#86/206 |
| Op. Margin | 0.92% | US#2,379/3,111 Sec#124/206 |
| Revenue Growth | 11.05% | US#1,226/3,111 Sec#84/206 |
| Earnings Growth | -21.15% | US#1,667/3,111 Sec#81/206 |
| Financial Health | ||
| Debt Ratio | 5948.00% | US#2,998/3,111 Sec#205/206 |
| Total Debt | $8.92B | US#439/3,111 Sec#25/206 |
| FCF | $4.39B | US#173/3,111 Sec#13/206 |
| Cash | $3.94B | US#239/3,111 Sec#13/206 |
| Current Ratio | 0.91x | US#2,394/3,111 Sec#197/206 |
| Net Debt/EBITDA | 1.65x | US#1,230/3,111 Sec#71/206 |
| Dividend | ||
| Div. Yield | 0.89% | US#1,347/3,111 Sec#31/206 |
| Div. Growth | 0.64% | US#1,168/3,111 Sec#41/206 |
| Performance | ||
| 1Y Return | 51.94% | US#731/3,111 Sec#54/206 |
| 1M Return | -1.37% | US#1,932/3,111 Sec#131/206 |
| From 52W High | -3.10% | US#552/3,111 Sec#32/206 |
| 1Y MDD | -20.61% | US#728/3,111 Sec#12/206 |
| Trading | ||
| Volume | 1,612,562 shares | US#1,295/3,111 Sec#79/206 |
| Trading Value | $377M | US#382/3,111 Sec#27/206 |
| Per Share | ||
| EPS | $7.06 | US#417/3,111 Sec#31/206 |
Company Info
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.